SCHEMBL26535807

SCHEMBL26535807

c1cc(-c2cccc(-c3nc4cccnc4o3)c2)cc(-c2ccc3c4ccccc4c4ccccc4c3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
KDM4E B2RXH2 3/20 0.44
TP53 P04637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
HSD17B10 Q99714 2/20 0.44
NPSR1 Q6W5P4 2/20 0.42
MAPT P10636 2/20 0.42
HCRTR1 O43613 1/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
SGMS2 Q8NHU3 10/20 0.41
KMT2A Q03164 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26535958 0.99 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL13052998 0.81 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL17231525 0.80 KDM4E (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL17231514 0.80 KDM4E (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL26535783 0.80 KDM4E (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL26535788 0.80 KDM4E (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL12910410 0.79 HPGD (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL9867688 0.79 SGMS2 (0.55) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL26535952 0.79 KDM4E (0.54) SMN1; SMN2ALDH1A1HPGDKDM4ETP53
SCHEMBL26535954 0.79 KDM4E (0.54) SMN1; SMN2ALDH1A1HPGDKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 US disclosed
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CCNT1, CCNE2, SCO2 SMN1; SMN2 1253/4885ALDH1A1 240/4885HPGD 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.